Cargando…

Individualized ibuprofen treatment using serial B-type natriuretic peptide measurement for symptomatic patent ductus arteriosus in very preterm infants

PURPOSE: Plasma level of B-type natriuretic peptide (BNP), an emerging, sensitive, and specific biomarker of hemodynamically significant patent ductus arteriosus (PDA), rapidly decreases in infants receiving cyclooxygenase inhibitors for ductal closure. We investigated the usefulness of serial BNP m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Jeonghee, Lee, Eun Hee, Lee, Jee Hyun, Choi, Byung Min, Hong, Young Sook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Pediatric Society 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500385/ https://www.ncbi.nlm.nih.gov/pubmed/28690644 http://dx.doi.org/10.3345/kjp.2017.60.6.175

Ejemplares similares

Correlation of B-type natriuretic peptide levels and echocardiographic parameters in preterm infants with patent ductus arteriosus
por: Jeong, Hyun Ah, et al.
Publicado: (2016)

Plasma B-type natriuretic peptide cannot predict treatment response to ibuprofen in preterm infants with patent ductus arteriosus
por: Oh, Seong Hee, et al.
Publicado: (2020)

Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment
por: Yoo, Hani, et al.
Publicado: (2017)

Single-dose prophylactic ibuprofen therapy for patent ductus arteriosus in preterm infants
por: Kim, Chae Young, et al.
Publicado: (2022)

Comparison of oral acetaminophen with oral ibuprofen on closure of symptomatic patent ductus arteriosus in preterm neonates
por: Ghaderian, Mehdi, et al.
Publicado: (2019)

The Effect of Ibuprofen Exposure and Patient Characteristics on the Closure of the Patent Ductus Arteriosus in Preterm Infants
por: Engbers, Aline G. J., et al.
Publicado: (2022)

Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosus
por: Engbers, Aline G.J., et al.
Publicado: (2020)

Baseline cardiac output and its alterations during ibuprofen treatment for patent ductus arteriosus in preterm infants
por: Hsu, Kai-Hsiang, et al.
Publicado: (2019)

B-Type Natriuretic Peptide Assay for the Diagnosis and Prognosis of Patent Ductus Arteriosus in Preterm Infants
por: Kim, Joon Sik, et al.
Publicado: (2012)

Effect of Nonintervention vs Oral Ibuprofen in Patent Ductus Arteriosus in Preterm Infants: A Randomized Clinical Trial
por: Sung, Se In, et al.
Publicado: (2020)

Echocardiographic Evaluation of Patent Ductus Arteriosus in Preterm Infants
por: Arlettaz, Romaine
Publicado: (2017)

Isoprostanes as Biomarker for Patent Ductus Arteriosus in Preterm Infants
por: Coviello, Caterina, et al.
Publicado: (2020)

Editorial: Management of Patent Ductus Arteriosus in Preterm Infants
por: Atasay, Begüm, et al.
Publicado: (2021)

Comparison of Oral Acetaminophen Versus Ibuprofen in Premature Infants With Patent Ductus Arteriosus
por: Bagheri, Mohammad Mehdi, et al.
Publicado: (2016)

Percutaneous Patent Ductus Arteriosus (PDA) Closure in Very Preterm Infants: Feasibility and Complications
por: Backes, Carl H., et al.
Publicado: (2016)

Anterior Minithoracotomy vs. Transcatheter Closure of Patent Ductus Arteriosus in Very Preterm Infants
por: Lenoir, Marien, et al.
Publicado: (2021)

Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns
por: Flint, Robert B., et al.
Publicado: (2018)

Conservative Treatment Without Any Intervention Compared With Other Therapeutic Strategies for Symptomatic Patent Ductus Arteriosus in Extremely Preterm Infants: A Nationwide Cohort Study in Korea
por: Shin, Jeonghee, et al.
Publicado: (2021)

Limited effects of intravenous paracetamol on patent ductus arteriosus in very low birth weight infants with contraindications for ibuprofen or after ibuprofen failure
por: Roofthooft, Daniëlla W. E., et al.
Publicado: (2015)

Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial
por: Dani, Carlo, et al.
Publicado: (2020)

Lung function in very preterm infants with patent ductus arteriosus under conservative management: an observational study
por: Chen, Hsiu-Lin, et al.
Publicado: (2015)

Multiscale Modeling Is Required for the Patent Ductus Arteriosus in Preterm Infants
por: Ho, Harvey, et al.
Publicado: (2022)

Plasma Amino Acid Concentrations at Birth and Patent Ductus Arteriosus in Very and Extremely Preterm Infants
por: Huizing, Maurice J., et al.
Publicado: (2021)

Effects of prophylactic oral ibuprofen on the closure rate of patent ductus arteriosus in premature infants
por: Ding, Yanjie, et al.
Publicado: (2018)

Serial echocardiographic assessment of evolution of ductus arteriosus in preterm infants
por: Su, Bai-Horng
Publicado: (2014)

Oral ibuprofen is superior to oral paracetamol for patent ductus arteriosus in very low and extremely low birth weight infants
por: Lu, Jinmiao, et al.
Publicado: (2019)

N-terminal pro-brain natriuretic peptide measurements in hemodynamically significant patent ductus arteriosus in preterm infants
por: Alenazi, Shehab Ahmed
Publicado: (2016)

Impact of Patent Ductus Arteriosus and Subsequent Therapy with Ibuprofen on the Release of S-100B and Oxidative Stress Index in Preterm Infants
por: Demir, Nihat, et al.
Publicado: (2014)

Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus
por: Al-lawama, Manar, et al.
Publicado: (2017)

Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: A randomized controlled trial
por: Yang, Bo, et al.
Publicado: (2016)

When to Treat Hemodynamically Insignificant Patent Ductus Arteriosus in Preterm Infants
por: Al-Abdi, Sameer Y.
Publicado: (2012)

Predictors of successful patent ductus arteriosus closure with acetaminophen in preterm infants
por: Vaidya, Ruben, et al.
Publicado: (2020)

Current Controversy on Platelets and Patent Ductus Arteriosus Closure in Preterm Infants
por: Sallmon, Hannes, et al.
Publicado: (2021)

Management of patent ductus arteriosus in very preterm infants in England and Wales: a retrospective cohort study
por: Al-Turkait, Asma, et al.
Publicado: (2022)

Safety and Feasibility of Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-/Ibuprofen-Resistant or -Contraindicated Preterm Infants: A Case Series
por: Oshima, Ayumi, et al.
Publicado: (2020)

Current Status of Therapeutic Strategies for Patent Ductus Arteriosus in Very-Low-Birth-Weight Infants in Korea
por: Lee, Jin A, et al.
Publicado: (2015)

Patent Ductus Arteriosus in Preterm Infants: Do We Have the Right Answers?
por: Abdel-Hady, Hesham, et al.
Publicado: (2013)

Turkish Neonatal Society guideline on the management of patent ductus arteriosus in preterm infants
por: Köksal, Nilgün, et al.
Publicado: (2018)

Controversy in the diagnosis and treatment of hemodynamically significant patent ductus arteriosus in preterm infants
por: Sung, Se In
Publicado: (2019)

Respiratory Trajectory after Invasive Interventions for Patent Ductus Arteriosus of Preterm Infants
por: Wei, Yu-Jen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6m3dqrm66b612nhrkqrqlnbdq2